Third Generation CAR T Cell Study Supports Use Of BioOra's Automated Manufacture For Phase 2 Trial
BioOra together with its founding partner, the Malaghan Institute of Medical Research, announced clinical results from the ENABLE phase 1 clinical trial at the 65th American Society of Hematology (ASH) Annual Meeting in San Diego.
Source: scoop.co.nz